Anita Zaidi: Why Only 2% of Health Research and Development Goes to Women’s Conditions
Anita Zaidi, President of Gates Foundation, shared Pivotal’s post on LinkedIn:
“Data is one of the most powerful tools we have, and yet, it’s still largely missing from women’s health work.
Less than 2% of health research and development dollars go to conditions that only affect women, and clinical trials rarely study sex or gender differences in their results.
Few have done more to help close that gap than Melinda French Gates.
Over the last decade, she’s committed millions of dollars to women’s health research, and her work through Pivotal continues to move the needle.”
Pivotal shared a post on LinkedIn:
“Women account for 80% of autoimmune diseases.
Being a woman doubles your risk of dementia.
Cardiovascular disease is the leading cause of death for women worldwide.
Despite the outsized impact of these conditions, there’s still so much we don’t know about them due to decades of underinvestment in women’s health.
These stats from Wellcome Leap show why closing the women’s health gap is ‘a moral and economic imperative.'”
Stay updated with Hemostasis Today.
-
Sep 21, 2026, 15:49Omid Khalafi: Gating Strategy and How Do We Decide Which Cells to Analyze
-
Sep 21, 2026, 15:44Levacetylleucine: A New Therapeutic Approach to Ataxia Telangiectasia
-
Sep 21, 2026, 15:40Andreas Tridimas: The Diagnostic Traps of Lipaemic Blood – Why a Normal Amylase Can Mislead You
-
Sep 21, 2026, 15:33Arsene Mekinian: Exploring Cardiac Involvement in Behçet’s Disease
-
Sep 21, 2026, 15:23Anis Mahjoubi: MRI Findings of Krukenberg Tumors
-
Sep 21, 2026, 15:08Fikreab Tesfaye Tefera: 10 Practical Take-Home Points for Diagnosing Iron Deficiency Anemia
-
Sep 21, 2026, 14:10Aswin K Mohan: Lessons from TRANSCON 2026 – Building Resilient Blood Supply Systems Before Crisis Hits
-
Sep 21, 2026, 14:00Vincent Lu: Beyond PT and aPTT – How Hemostasis Evolves Across a Lifetime
-
Sep 21, 2026, 13:56Alex Knapp: Emerging Technologies and Advances in Hemophilia Care